<DOC>
	<DOCNO>NCT01970241</DOCNO>
	<brief_summary>Despite significant problem out-of-control glucose level patient diabetes receive corticosteroid variety illness , publish protocol address adequately treat corticosteroid-induced hyperglycemia . Investigators propose test protocol use schedule dose NPH ( Neutral protamine Hagedorn ) insulin inpatient diabetes receive corticosteroid . NPH insulin action ideally time counteract corticosteroid-induced hyperglycemia , dose add patient 's usual insulin regimen time correspond corticosteroid dose regimen . Investigators prospectively enroll eligible consented patient diabetes receive corticosteroid part treatment large county hospital , randomize intervention control group , monitor glucose level inpatient stay . The protocol demonstrate improve control glucose level minimal risk hypoglycemia , provide practical readily implementable protocol use NPH insulin therapy corticosteroid-induced diabetes .</brief_summary>
	<brief_title>Inpatient Diabetes Corticosteroids</brief_title>
	<detailed_description>As .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Prior history diabetes Able provide inform consent Receiving corticosteroid hospitalize great 10 mg/d prednisone equivalent dexamethasone methylprednisolone Expect hospitalize 48 hour Renal failure GFR ( glomerular filtration rate ) &lt; 30 ml/min/1.73m2 ALT ( alanine aminotransferase ) &gt; 2 time upper normal laboratory</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>corticosteroid</keyword>
	<keyword>diabetes</keyword>
	<keyword>insulin</keyword>
</DOC>